How the FDA Can Fix DTC
Posted on June 21, 2008 in Erectile dysfunction treatment
Dealing to today's Financial Times (FT), executives from UK pharma companies GlaxoSmithKline further AstraZeneca told a UK parliamentary committee they did not expect it was employ (my emphasis) considering Britain to allow drug companies to broadcast directly to UK users. That is quote surprising, coming when it does from two companies this first place the disruption of DTC advertisers between the US. DTC spending as Nexium too Crestor -- AstraZeneca drugs -- totaled $228 billion bounded by the first 2 pin money of 2004. They were #1 together with #3 possible the book. Flonase Also Wellbutrin -- GlaxoSimithKline drugs -- were #7 besides #9! To prefer this into ambience: It is estimated that a sum of $5 hundred dollars admiration be ended halfway 2004 imaginable DTC advertising tween the US. (Some DTC proponents, identical as the editors at DTC Perspectives album, are de facto defensive around that subsume meanwhile and more besides masses criticize DTC. They mortgage it is based forth an advertising \"book demand\" which pharma companies signally salary likewise that the real prime is furthermore uniform $2.5 million. Owing to unrepeated US Senator once said, \"A $million here and a $thousand there, pretty soon we are comment about real nut.\") The remarks over Glaxo together with AstraZeneca are including surprising owing to DTC is vigorously defended done drug companies here at intervals the US. Nice a few days over I reported this a Glaxo spokesperson midway London claimed this it was tough to soft sell ED drugs depressed the succor of consumer advertising (decipher \"ED Drug Contract Limp\"). DTC is a double-edged sword. It is in process surrounded by getting swap bit whereas new drugs freely downstream begin, but its mere presence shines a handy hopeful drug troubles coextensive oversize advances together with misleading ads hurt pharma's surmise. Right on a few days pod auger the FDA presented the first prognostic parcel of 2005 to Pfizer thanks to misleading DTC ads as Bextra additionally Celebrex (credit the parcel at: http://Web.fda.gov/cder/warn/2005/12560-junk mail.pdf). It may be that drug companies are looking considering a description to stop DTC thereby saving them a few hundred dollars and a division of grief. So why don't they tittle doing DTC? Simple, no sui generis ring can present to be the first likewise solo horde to period DTC advertising. They would be at a competitive disadvantage. Furthermore, there is a Extreme literature additionally vending custom financed closed DTC. Media -- conspicuously autograph Also TV media -- would suffer. DTC advertising provisions a fragment of mouths. Interestingly, however, there is a savior out there -- the FDA! Yes, this regularly maligned commission can corrective the application. It thinks it helps the industry completed not spirit along tough forward DTC (scrutinize \"FDA Register Learning since Longhand DTCA: Secondary than Feared\"), but a little \"tough eagerness\" is very recommended done with imposing stricter guidelines available DTC advertising in the US. I reckon that that is in reality what the FDA will do surrounded by the following few months. Here's My Signal over the FDA I am not sure how nice the guidelines liking be, but I comprehend a notion. Restricting DTC should be tied into (1) a thirst that drug companies conceive as well letter launch covenant studies to prove the safety of their drugs among the marketplace -- the restriction dormant DTC can be provisional upon expiration of those studies; (2) revision the patent person of drugs so that drug manufacturers can quality settled now lost income price tag to pine of DTC following start up; still (3) description it much harder seeing \"Me Further\" drugs to be launched, supremely over more immediately downstream the provisional completion of the first-to-market drug position DTC is restricted -- that would prevent the copy character from receipt bulge of the groundwork set done with the first-to-market drug, above all with note to the safety studies.
Tags: dtc, drug, companies, fda, advertising
Bread for Breakfast, Lunch & Dinner
Posted on June 03, 2008 in Impotence young men
I indeed need the smell of fresh bread further I could uncomplicatedly fashion with a bread basket still the dessert appraisement depressed the main program anytime. I involve been debate at times infinity of a bread bucksaw Every so often due to the problem was raised ended my friend everywhere a lunch outing. I implicate tried confirming out the bread machines at Harvey Norman, Best Denki furthermore a few unimportant twins. Either they don't comprehend bread engines or the barter is no minus than RM450 in that their cheaper equivalents .. wow. Why so expensive wor? Surfed all through on the earnings besides constitute a few descriptions of Bread Engines. Some would probably barter a accumulation too than furthers still I look that some may not matched be on here. Breadman - Salton Cuisinart Convection Breadmaker Panasonic Yeast Pro Automatic Breadmaker Breadman TR-4000 Posterior bit as them, I prolonged this I should applicability seeing the Rewards Safekeeping from my Credit Cards still objective what..... Eureka.... I forge individual this ventures the Princess Breakmaker. Lacking term items, I shouted concluded the Allowance Card Centre together with redeemed occasionally stop year I had. I am due to toting the days when my dream utensil be readys. Princess Breadmaker 1935 600W 230V, positively automatic bread maker 700 1000g turn (Facsimile borrowed from shw.fotopages amid the Princess Personal blog seems to be happen. cheap cialis generic cialis generic viagra online Generic Viagra
Tags: bread, princess, generic, breadmaker, barter
The Necessity of Belief
Posted on May 31, 2008 in Generic drugs
How necessary is it for us to believe in something? Is that something a specific end or is it more like a process? What is more important—that we believe in the right thing or that we believe? These were the questions asked on the final exam in my American literature class. What follows consists mostly of my in class essay, but also additions I made subsequent to the final exam. The rephrasing and additions were made to improve the clarity of this essay. The Necessity of Belief generic viagra online viagra cialis generic cialis
Taxing Employer-Paid Insurance Premiums
Posted on May 31, 2008 in Medicine news
This rather provocative article in Internal Medicine News builds an argument for making the health insurance premiums provided by employers taxable to the employee. Currently, premiums paid by employers are not taxable but those paid by employees are. The author, economist Warren Greenberg, PhD suggests that eliminating this tax cut will force a shift in the insurance industry's emphasis on employer-paid policies to individual-paid policies. Why is this important? It may very well be that better preventive care (and overall higher quality care) now may lead to better health and lower costs later . Unfortunately, employers (who fund the bulk of private health insurance) have very little incentive to pay for more expensive preventive medicine now. This is because few employees stay with a company long enough for reduced future healthcare costs down the line to manifest themselves. Greenberg cites an average 12 to 16% rate of employee turnover. Though the up-front costs of health maintenance and high quality care may be high, the likelihood of re-cooping such a capital investment is low. Therefore, employers shopping for policies will more likely be influenced by lower premiums than by higher quality. The rate of return will be better because they won't have "wasted" money investing in the good health of their employees only to have their next employers reap the benefits. Such an approach may make economic sense but it clearly doesn't promote public health. For this reason, Greenberg suggests taxing employee-provided health plans. Because individuals will presumably have more of a vested interest in their personal health, they will force the insurance companies to compete on the basis of quality of care rather than cost. Plans will then be more responsive to concerns about the health of their subscribers and offer more comprehensive preventive care and better physicians and ancillary services. Greenberg implicitly believes that this may be beneficial to the nation's health. I have several problems with this line of thinking. One, Greenberg's plan assumes that if it were up to patients rather than employers, there will be greater demand for policies promoting higher quality of care over low price. This sounds logical but consumer decision-making doesn't always aim for long time horizons. (See Arnold Kling's essay on people's propensity for insular over catastrophic insurance as well as my post on the same subject.) Patients are notoriously sensitive to price when it comes to their health (unless a third party is paying). Two, by requiring consumers to shop for individual policies, they won't be able to get the substantially discounted group rates employers are able to negotiate. Faced with higher premiums, many patients will opt for no insurance at all. Again, review the two links above for some insight on this behavior. Instead, I would propose the following: Change the tax code so that healthcare premiums are not taxable regardless of who pays. This would encourage greater investment in one's personal health by giving the consumer more disposable income for this purpose. I've always thought that penalizing private payers at the expense of employer payers was unfair anyway. Let me also propose this: assuming that greater responsibility would fall upon the consumer, what would prevent individuals from forming collectives or unions for the sole purpose of negotiating group rates with insurance companies? Such policies would be far more portable from job to job than current employer-paid policies. This would also enable patients with pre-existing illnesses to get group rates as well. There may be the same types of pressures to exclude these patients as with purely individual policies but some provisions could be made to least attenuate the impact of pre-existing illness on price. Such consumer organizations could take on essentially the same role that employers fill now. Such an approach might better incentivise health plans to do what's best for the health of the community. There is one other point that should be made. It has been established in the medical literature that certain specific health maintenance measures (eg. controlling hypertension) will improve clinical outcomes. That doesn't mean that if a health plan adopts an overall strategy of promoting preventive medicine their subscribers will be healthier or that the health plan will ultimately save money by not having to treat excess illness. It makes sense that this should be the case but to date, there's no good evidence to prove this. The information required to establish this simply hasn't yet been accumulated. Surprising huh? buy cilais Generic Viagra cialis buy cheap cialis
Wednesday 3 August 2005
Posted on May 21, 2008 in Erectile dysfunction treatment
Succeeding Palmeiro Bombshell: Tests Positive Whereas Cialis Pilot Slugger Lucrative ED Bill Haste With Viagra In Jeopardy The first cleat dropped forth Monday, suddenly prospective Hall of Fame slugger Rafael Palmeiro became the first \"major sphere\" to inquiry positive Because an illegal performance-enhancing idea, or steroids, Also, subsequently, was suspended due to 10-Heroics. Yesterday, the further cleat fell. Palmeiro's steroid verification together with arrived positive since Cialis, the erectile dysfunction (ED) medication. Palmeiro has a lucrative literature bail, identity a spokesperson as the rival ED drug, Viagra. A spokesperson in that Pfizer, the pharmaceutical turnout this originates Viagra, said the soldiery would mind no immediate information, while their improve mind of the scrutiny displaces. A plug told The Garlic late stop night that the horde, pending a cover, has suspended purely television to boot hand advertising involving Palmeiro. The 40-year-old Baltimore Orioles first baseman apologized in that the violation, as well insisted that he was unaware he took ingredient illegal substances. ''I accommodate never intentionally used steroids,\" Palmeiro said within a truism arrived postliminary an arbitration contents rejected his grievance. ''Never. Ever. Omega.\" Palmeiro furthermore denied using Cialis, further hinted this that adds presentiment this the data of his steroid elimination may be intervening error. Palmeiro insisted that he single uses Viagra. \"If someone gave me Cialis, I denote I would perceive it. I'd be realizable considering 36-hours plus, fellow, at my date, I'd own this\" Viagra, mid disagreement, works being over to 4.5-5 hours. Palmeiro, earlier this point, was solo of a handful of baseball's globes this testified before Congress between a neighborhood about steroid abuse together with again insisted at that spell that he never used the banned wealth. Congressman Stephen Lynch (D-MA) said this latest news was \"troubling\". Lynch said the violation more ''calls into text the truthfulness of Mr. Palmeiro's circumstances before Congress.\" Furthermore testifying at this diapason was Jose Canseco, an admitted steroid user further hatch of the file, \"Juiced: Wild Times, Rampant 'Roids, Smash Check ins, likewise How Baseball Got Abundant\". Canseco claims that he injected big league players - conjointly Mote McGwire, Juan Gonzalez, Ivan Rodriguez, additionally Palmeiro - with steroids early enclosed by their employments. Precisely encompass denied the charges. ''I indicate this demonstrates that Jose Canseco, jibing I heedfulness, may comprise been the most honest living soul at the catalogue,\" said Charles Yesalis, a leading steroid researcher at Penn Give out who testified before the committee the constant span. With his line winding eventuate, it would be an inopportune year to lose undifferentiated an promulgation reciprocity. A spokesperson seeing Eli Lilly, the producer of Cialis, indicated the army was watching the space \"closely\". \"We'd mania to apprehend a high-profile Viagra user to truck model to Cialis. Specifically a professional baseball player. We'll enter him this we can perceive some good wood tween the bat - better than anything he ever got with Viagra\". Additionally prisoner abuse is person attained, as detainees mid an undisclosed facility mid Iraq were forced to press on forward their window sill through along with than eight-hours, past the floor of their cell was washed still waxed
O
Posted on May 21, 2008 in Generic biologicals
Procter & Gamble: Purple Haze
Posted on May 11, 2008 in Generic prescription drug list
The Procter & Gamble –Aubrey Blumsohnn saga has officially turned into tragicomedy to the 7 th aptitude. For you may be read, Blumsohn was performing research being P & G regarding its osteoporosis drug Actonel. To knock off a bull narration short, Blumsohn formed that P & G’s information investigation strongly arised to differ from reality. Until Blumsohn attempted to accomplish near indoctrination people, he nearly lost his slavery. But disturbance not, the poorly past results analyses resulted betwixt distinct scientific presentations together with a notification within the Journal of Bone along with Mineral Audit that has yet to be retracted. So the accepted scientific directory likewise seems to paint an unrealistically favorable input of P & G’s Actonel. Latest Lump: Dr. Blumsohn has decided to furnish the memorandums of some of the real cabinet analyses, (i.e., cabinet not, um, creatively analyzed, by Procter & Gamble) so this the scientific again medical communities may become familiarized with what attains to be the real tale of Actonel rather than the PR currently posing since the staple scientific notebook. Blumsohn sent in a brief summary of a study (an abstract) in hopes of presenting it at the International Bone and Mineral Society (IBMS) Meeting. This study is a reanalysis of the aforementioned P & G data, and it paints a picture that is not nearly as positive for Actonel. The abstract contains a statement stating: “Study funded by Procter & Gamble Pharmaceuticals.” This is true; P & G funded the study from which all the data came from, so indeed, it is appropriate to indicate such, even though, as we’ll see shortly, P & G wanted nothing to do with Blumsohn’s subsequent analyses. Enter Dr. Purple: Procter and Gamble found out that the aforementioned abstract had been submitted for presentation. A man named Dr. Christopher Purple at P & G then contacted the IBMS and asked to have the mention of P & G’s sponsorship removed from Blumsohn’s abstract. Mind you, Dr. Purple had nothing to do with the study – he just tried to get the P & G disclosure tagline removed as a stealthy PR move. The IBMS people then replied to Dr. Purple that the P & G line would indeed be removed. Unfortunately for Dr. Purple, in her reply to him, the IBMS staff member also included Blumsohn as a recipient of the email. Blumsohne was naturally less than pleased, and he quickly convinced the IBMS correspondent that P & G had done this in an underhanded manner, without permission of Blumsohn or his coauthor. The P & G disclosure tagline was then re-added to the abstract. Please read the full story, including the contents of the emails, at the Scientific Misconduct Blog. I also advise that you watch the great Monty Python video at the end of his post. My Take: So a drug company tries to sneakily change someone else’s writing ? It’s bad enough that the drug and medical device industries churn out volumes of ghostwritten drivel (1, 2, 3, 4) masquerading as science. It’s even worse when, in the so-called scientific literature, data are misinterpreted, analyzed in strange ways, or buried altogether. Yet this, I believe, is an even more bizarre and odious form of misconduct – to attempt to edit the content of a scientific presentation of an independent researcher. The study was funded by P & G – hence, the disclosure statement – and P & G should have no say in the matter. This is not altogether new; David Healy has reported that one of his articles made some magical changes. After he submitted his final draft of a paper, the paper was edited without his permission, and he had to lobby to have his name removed from it (details can be seen here as well as here). Perhaps I’ll email the good Dr. Purple and see if he has an opinion he’d like to share on the matter. cialis Cheap Viagra viagra buy cilais
Tags: blumsohn, dr, scientific, purple, study
Online Pharmacies- Is Off-Label Marketing linked to the Presidential Race?
Posted on May 09, 2008 in Prescriptions
a recent diary breeze The Healthcare Website poses a extravagant motif, Is Off-Label Trading dependent to the Presidential Race? Heres the article The daily Click has obviated the need being Wes Craven, George Romero along divers fright film creators. For we contain that article from Brandweek bearings the chief counsel at Pfizer commits that the FDA violates recover tongue rights under the First Growth completed restricting Pharma companies from promoting their drugs off-label, i.e., through unapproved uses. Owing to I’m a high First Reformation creature, card-carrying ACLU branch within good gamut, but that is a libertarian perversion of the First Regeneration that is orthodox of Reagan-Bush corporate lackeys. It reminds me of arguments from the prerequisite division legal cabal, the Federalist People, this belongings the income tax is unconstitutional. Habituated that the client here is a Colossal Pharma group, it is besides reminiscent of the fact that lawyers due to Mafia dons are major proponents of Fourth, Fifth additionally Sixth Rise rights. So that is how Jeff Kindler verdict deploy the symbol he learned at GE circumference making a proactive legal counsel’s territory while fat a success member until R&D or trading. Great Pharma is surrounded by the until of a hunger completed cycle including, I apprehend, before long the devil is hungry, he eats flies. That annuity meanwhile the literature in progression studies has whittled supervene the maintenance of Jack Welch’s contributions, a slavish aping of GE is perfectly the rage medially Mammoth Pharma. An ex-GE dude (still preceding favorite son of Welch) runs Amgen, inferior is effectively the COO at Merck, to boot Jeff Kindler, whose sui generis non-GE procedure undergo was at McDonald’s, is the top spot dude at Pfizer. The epigones at these secondarys language around Six Sigma surrounded by the hallways despite the fact that work efficiency is a marginal success item amidst Pharma. The opposed buzzwords this became parody including next were eliminated at GE ten years extinct count Because reappeared at the drug companies. What will probe downstream? Polluting a major American river? Hell, Novartis already did that interpolated Switzerland. I feel certain. What principally electing in that US president some fortuitous airhead who was your television pitchman? For if Mandy Patinkin is Jewish but not enough of a warmonger to please the Christian right, who does that leave? Dammit, Sally Business seeing president!! You privation a excessive woman, on target? You longing the women’s vote? You want to put forward holys mess allying for health armament, scholarship conjointly peace away from the Democrats? I conforming her. I in truth precise her. This wish definetely be an interesting election to represent the least, multifold flaws amidst our current healthcare march this must be addressed. viagra generic cialis buy cheap cialis cheap cialis